A carregar...

Double-blind evaluation of oral L-prolyl-Lleucyl-glycine amide in Parkinson's disease.

A 4-month double-blind study comparing the effect of increasing oral doses (up to 1.0 g daily) of synthetic L-proyl-L-leucyl-glycine amide (PLG) and placebo in 20 parkinsonian patients showed no significant improvement in objective scores of functional disability. However, important trends and some...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Barbeau, A., Roy, M., Kastin, A. J.
Formato: Artigo
Idioma:Inglês
Publicado em: 1976
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1956816/
https://ncbi.nlm.nih.gov/pubmed/3279
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!